Factors associated with uptake of contraceptives among HIV positive women on dolutegravir based anti-retroviral treatment-a cross sectional survey in urban Uganda

Factors associated with uptake of contraceptives among HIV positive women on dolutegravir based anti-retroviral treatment-a cross sectional survey in urban Uganda

Abstract Background In May 2018, following the preliminary results of a study in Botswana that reported congenital anomalies in babies born to HIV-positive women taking dolutegravir drug, the WHO issued a teratogenicity alert. However, there are scarce data on the impact of this guidance on contrace...

Full description

Bibliographic Details
Main Authors: Leah Mbabazi, Mariah Sarah Nabaggala, Suzanne Kiwanuka, Juliet Kiguli, Eva Laker, Arthur Kiconco, Stephen Okoboi, Mohammed Lamorde, Barbara Castelnuovo
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Women's Health
Subjects:
Dolutegravir
Anti-retroviral treatment
Contraceptives uptake
Online Access:https://doi.org/10.1186/s12905-022-01842-7

Internet

https://doi.org/10.1186/s12905-022-01842-7

Similar Items